ISBD would like to thank their Supporting Corporations for 2023

The support received from these Corporations allows the ISBD to continue to offer valuable resources for professionals, those with lived experience and their carers, as well as to further initiatives to advance the diagnosis and treatment of bipolar disorders.

Platinum Supporting Corporations:

Bronze Supporting Corporations:

Alkermes

Intra-Cellular Therapies, Inc.

Additional Supporting Corporations:

Janssen Neuroscience (Pharmaceutical Companies of Johnson & Johnson)